The racism, the predatory politics, the banality and cruelty: we struggle to make sense of it, but JG Ballard foretold everything we are living through now

An Englishman drives into a new town and can’t see the warning signs. Richard Pearson is visiting Surrey to close down his late father’s home and settle his affairs and, everywhere he looks, the flag of St George is flying “from suburban gardens and filling stations and branch post offices”. How nice, he thinks, how festive.

Soon he learns the truth.

So runs the opening not of a recent piece of journalism, but a novel by JG Ballard, Kingdom Come, which despite being almost 20 years old anticipates today’s Britain with eerie precision. In the mid-2000s, Pearson reads up on his new surroundings, only to find the same headlines that assail us in the mid-2020s: “Every day the local newspaper reported attacks on an asylum hotel, the torching of a Bangladeshi takeaway, injuries to a Kosovan youth thrown over the fence into an industrial estate.”

Aditya Chakrabortty is a Guardian columnist

Kingdom Come by JG Ballard (Fourth Estate, £10.99). To support the Guardian, order your copy at guardianbookshop.com. Delivery charges may apply.

More than £3bn that could have been used for UK patients will go to big pharma for its branded products – money for care siphoned off for profit

Of Arthur Scargill it was said that he began each day with two newspapers. The miners’ leader read the Morning Star of course, but only after consulting the Financial Times. Why did a class warrior from Yorkshire accord such importance to the house journal of pinstriped Londoners? Before imbibing views, he told a journalist, he wanted “to get the facts”.

In that spirit, let us parse a deal just struck by the governments of Donald Trump and Keir Starmer. You may not have heard much about this agreement on medicine, but it is huge in both financial and political significance – and Downing Street could not be more proud.

A “world-beating deal,” boasts the science minister, Patrick Vallance. It “paves the way for the UK to become a global hub for life sciences,” claims the business secretary, Peter Kyle, with the government press release adding: “Tens of thousands of NHS patients will benefit.”

Aditya Chakrabortty is a Guardian columnist